Dorrapharma is engaged in R&D, manufacture and market of intermediates, APIs (Active Pharmaceutical Ingredients) and formulations. We own the core technologyadvantage in the professional area of bromination,enzyme/metal-catalyzed, nitration and hydrogenation, and obtain multiple core patents for invention.We stick to raising the value both for the company and customers, and strive creating more valuable product for the health of the life...
MOREReading a good book is like making a good friend, the longer the time ...
Sept. 03, 202 -- Impel NeuroPharma, Inc. today announced that the U.S. Food and Drug Admin...
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 蘇ICP備12056923號-1